Literature DB >> 33040036

Complete resolution of arrhythmia-induced hydrops fetalis in utero.

Monisha Narayanan1, Sypara Dhuka2, Srilatha Alapati3, Robert P Kauffman4.   

Abstract

A 21-year-old G3P2011 Caucasian woman at 27 weeks' gestation presented with fetal tachyarrhythmia between 240 and 270 beats per minute. Fetal supraventricular tachycardia, abdominal ascites, pleural effusion and pericardial effusion indicated hydrops fetalis. Management with digoxin and flecainide converted the fetus to sinus rhythm and resolved the ascites and pleural effusion within 4 days of treatment. Flecainide was discontinued at 31 weeks' gestation due to elevated liver enzymes. Intrahepatic cholestasis was treated with ursodiol. Caesarean section was performed at 37 weeks' gestation. Neonatal echocardiogram revealed a bicuspid aortic valve with mild regurgitation and a patent foramen ovale, and the infant showed no subsequent evidence of tachyarrhythmia or hydrops after delivery. Treatment of hydrops fetalis in the antenatal period is complex, and early diagnosis and treatment can quickly resolve supraventricular tachycardia-induced hydrops fetalis. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  materno-fetal medicine; neonatal health; pregnancy

Mesh:

Substances:

Year:  2020        PMID: 33040036      PMCID: PMC7552800          DOI: 10.1136/bcr-2020-235827

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Postnatal Outcomes of Fetal Supraventricular Tachycardia: a Multicenter Study.

Authors:  Kevin A Hinkle; Shabnam Peyvandi; Corey Stiver; Stacy A S Killen; Hsin Yi Weng; Susan P Etheridge; Michael D Puchalski
Journal:  Pediatr Cardiol       Date:  2017-06-29       Impact factor: 1.655

2.  Non-immune fetal hydrops: Are we doing the appropriate tests each time?

Authors:  W Kurdi
Journal:  J Prenat Med       Date:  2007-01

3.  Fetal supraventricular tachycardia at 12 weeks of gestation: diagnosis and follow up. A case report.

Authors:  Nathalie Jeanne Bravo-Valenzuela; Alberto Borges Peixoto; Edward Araujo Júnior; Gabriele Tonni
Journal:  Med Ultrason       Date:  2019-02-17       Impact factor: 1.611

4.  Supraventricular tachycardia with hydrops in a 27-week premature baby.

Authors:  P Abraham
Journal:  Int J Clin Pract       Date:  2001-10       Impact factor: 2.503

Review 5.  Society for maternal-fetal medicine (SMFM) clinical guideline #7: nonimmune hydrops fetalis.

Authors:  Mary E Norton; Suneet P Chauhan; Jodi S Dashe
Journal:  Am J Obstet Gynecol       Date:  2014-12-31       Impact factor: 8.661

6.  Fetal supraventricular tachycardia diagnosed and treated at 13 weeks of gestation: a case report.

Authors:  S Porat; E Y Anteby; Y Hamani; S Yagel
Journal:  Ultrasound Obstet Gynecol       Date:  2003-03       Impact factor: 7.299

7.  The many faces of hydrops.

Authors:  S Christopher Derderian; Cerine Jeanty; Shannon R Fleck; Lily S Cheng; Shabnam Peyvandi; Anita J Moon-Grady; Jody Farrell; Shinjiro Hirose; Juan Gonzalez; Roberta L Keller; Tippi C MacKenzie
Journal:  J Pediatr Surg       Date:  2014-10-29       Impact factor: 2.545

Review 8.  Cardiac Etiologies of Hydrops Fetalis.

Authors:  Shi-Min Yuan
Journal:  Z Geburtshilfe Neonatol       Date:  2017-05-23       Impact factor: 0.685

9.  Refractory fetal supraventricular tachycardia and obstetric cholestasis.

Authors:  Antonia W Shand; Jan E Dickinson; Luigi D'Orsogna
Journal:  Fetal Diagn Ther       Date:  2008-09-02       Impact factor: 2.587

10.  Fetal supraventricular tachycardia, treating the baby by targeting the mother.

Authors:  Aysha Husain; Zakariya Hubail; Rashed Al Banna
Journal:  BMJ Case Rep       Date:  2013-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.